All posts

Post-financing, is Intermap still a buy?

Beacon Securities analyst Russell Stanley said in a Sept. 29 report that Intermap Technologies  (Intermap Technologies Stock Quote, Chart, News, Analysts, Financials TSX:IMP) has materially improved its positioning to win new business following the closing of a C$28.8-million bought deal prospectus offering.

He maintained a “Buy” rating and C$5.50 target.

The offering, upsized from an originally announced C$20-million, included full exercise of the overallotment option. Priced at C$3.00 per share, it added 9.6 million shares and increased Intermap’s basic share count by 16% to 71 million. Net proceeds of about US$19-million should leave the Colorado-based geospatial intelligence company with US$27-million in cash and equivalents at the end of the third quarter, according to Stanley.

“This better positions Intermap to compete for business, given certain revenue opportunities (e.g. Indonesia) require bidders to meet balance sheet liquidity requirements,” he said.

Intermap specializes in high-resolution 3D terrain data and Earth surface models. It is currently working under a US$20-million contract awarded in January 2024 to deliver the first phase of Indonesia’s One Map program, covering roughly 10% of the country’s territory. The total program is estimated to represent a US$200-million revenue opportunity.

Indonesia recently issued a request for bids for the next phase of the program. Stanley noted that Intermap is already using the equipment specified, with the scope consistent with its current work, and that experience requirements should favour the incumbent. The RFB gives technical capabilities 60% of the scoring weight, compared with 40% for price. The project covers 1.6 million square kilometres divided into four lots, with Intermap expected to bid on all. Minimum balance sheet liquidity of about US$18-million is also required. Bids are due Oct. 7, with an award scheduled for Dec. 15 and contracts anticipated in January.

“Even if we see some slippage in timelines, this schedule sets up the Indonesian opportunity as a major potential catalyst for IMP in the near-term,” said Stanley.

The analyst also raised his valuation multiple to 13 times fiscal 2026 Adjusted EBITDA from 12 times, pointing to stronger odds of contract wins under liquidity-based criteria. While still at a 39% discount to the more than 21 times multiple assigned to peer BlackSky Technology, the move narrows the gap from earlier levels. Planet Labs trades at an even higher multiple, he added, though Intermap’s stronger expected margins and lower capex requirements should support superior free cash flow.

Stanley said that Intermap should generate Adjusted EBITDA of US$8-million on revenue of US$30-million in fiscal 2025, improving to US$21-million on US$56-million in 2026.

 

-30-

Tagged with: imp
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

AtkinsRéalis is “on fire”, this fund manager says

Greg Newman, senior wealth advisor and portfolio manager at Newman Group, ScotiaMcLeod, told BNN Bloomberg’s Market Watch on Sept. 25… [Read More]

1 hour ago

Sanuwave Health is a buy, this analyst says

Roth Capital Markets analyst Kyle Bauser reiterated a “Buy” rating and US$55.00 target price for Sanuwave Health (Sanuwave Health Stock… [Read More]

6 hours ago

The Constellation Software selloff is overdone, TD says

TD Cowen analyst David Kwan said on Sept. 25 that the recent sell-off in Constellation Software (Constellation Software Stock Quote,… [Read More]

1 day ago

Hammond Power is a top pick for this fund manager

Sprung Investment Management president Michael Sprung told BNN Bloomberg’s Market Watch on Sept. 23 that Hammond Power Solutions (Hammond Power… [Read More]

1 day ago

Buy beaten-down Sylogist, this analyst says

Paradigm Capital analyst Daniel Rosenberg reaffirmed his “Buy” rating and $10.00 target price for Sylogist (Sylogist Stock Quote, Chart, News,… [Read More]

1 day ago

Is E3 Lithium a buy?

Roth Capital Markets analyst Joe Reagor reaffirmed his “Buy” rating and C$3.00 target price for E3 Lithium (E3 Lithium Stock… [Read More]

1 day ago